LM103 TILs Injection

BIOLOGICAL2 trials

Sponsors

Suzhou BlueHorse Therapeutics Co., Ltd.

Conditions

Advanced MelanomaNon-Small Cell Lung Cancer

Phase 2

A Phase II Trial of LM103 in Advanced Melanoma

RecruitingNCT07310784

Suzhou BlueHorse Therapeutics Co., Ltd.Advanced Melanoma

Start: 2025-12-16End: 2028-12-31Target: 92Updated: 2026-05-12

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

RecruitingNCT07444437

Suzhou BlueHorse Therapeutics Co., Ltd.Non-Small Cell Lung Cancer

Start: 2026-02-26End: 2028-12-31Target: 45Updated: 2026-05-13